Healthcare provider profile · identity verified

Amber O Vick, MD

Family Practice · NEW LONDON, MN · NPI 1972519213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	383	80
Lisinopril	Lisinopril	295	82
Losartan Potassium	Losartan Potassium	274	69
Simvastatin	Simvastatin	269	60
Omeprazole	Omeprazole	257	80
Gabapentin	Gabapentin	239	47
Hydrochlorothiazide	Hydrochlorothiazide	218	63
Amlodipine Besylate	Amlodipine Besylate	216	59
Atorvastatin Calcium	Atorvastatin Calcium	191	60
Furosemide	Furosemide	182	36
Metoprolol Succinate	Metoprolol Succinate	178	46
Jantoven	Warfarin Sodium	149	suppressed
Sertraline Hcl	Sertraline Hcl	139	37
Rosuvastatin Calcium	Rosuvastatin Calcium	121	37
Trazodone Hcl	Trazodone Hcl	121	35
Ozempic	Semaglutide	120	20
Fluoxetine Hcl	Fluoxetine Hcl	93	11
Fluticasone Propionate	Fluticasone Propionate	92	44
Duloxetine Hcl	Duloxetine Hcl	91	16
Metformin Hcl	Metformin Hcl	90	23
Eliquis	Apixaban	89	16
Potassium Chloride	Potassium Chloride	82	15
Metoprolol Tartrate	Metoprolol Tartrate	80	23
Prednisone	Prednisone	79	24
Spironolactone	Spironolactone	79	14
Atenolol	Atenolol	75	17
Carvedilol	Carvedilol	71	13
Alendronate Sodium	Alendronate Sodium	68	19
Warfarin Sodium	Warfarin Sodium	68	18
Escitalopram Oxalate	Escitalopram Oxalate	67	suppressed
Baclofen	Baclofen	64	suppressed
Pravastatin Sodium	Pravastatin Sodium	63	20
Bupropion Xl	Bupropion Hcl	62	14
Tramadol Hcl	Tramadol Hcl	61	12
Venlafaxine Hcl Er	Venlafaxine Hcl	61	13
Quetiapine Fumarate	Quetiapine Fumarate	58	suppressed
Terazosin Hcl	Terazosin Hcl	52	suppressed
Famotidine	Famotidine	51	18
Tamsulosin Hcl	Tamsulosin Hcl	51	16
Pantoprazole Sodium	Pantoprazole Sodium	50	16
Allopurinol	Allopurinol	49	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	suppressed
Metformin Hcl Er	Metformin Hcl	48	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	suppressed
Myrbetriq	Mirabegron	45	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Ezetimibe	Ezetimibe	42	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	14
Nifedipine Er	Nifedipine	39	suppressed
Buspirone Hcl	Buspirone Hcl	36	12
Latanoprost	Latanoprost	36	suppressed
Trospium Chloride	Trospium Chloride	34	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	12
Lovastatin	Lovastatin	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Estradiol	Estradiol	31	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Metolazone	Metolazone	29	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Methotrexate	Methotrexate Sodium	27	suppressed
Amoxicillin	Amoxicillin	26	18
Azelastine Hcl	Azelastine Hcl	26	11
Januvia	Sitagliptin Phosphate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Rexulti	Brexpiprazole	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Vilazodone Hcl	Vilazodone Hcl	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Lorazepam	Lorazepam	22	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Nystatin	Nystatin	20	13
Albuterol Sulfate Hfa	Albuterol Sulfate	19	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	13
Clonazepam	Clonazepam	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error